Search research articles
Contact Us
Filters
Showing results (1-10 of 233) with videos related to
Page
of 24
Sort By:
Journal of Hypertension
|
May 23, 2002
Clinical value of diastolic dysfunction in hypertension
Enrico Agabiti Rosei
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
January 29, 2013
Reduction of Cardiovascular Risk through Angiotensin II Type 1 Receptor Antagonism : Focus on Olmesartan Medoxomil
Enrico Agabiti Rosei
Drugs
|
April 24, 2003
[Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy]
Enrico Agabiti-Rosei
Current Medical Research and Opinion
|
October 26, 2016
The fixed-dose combination of lercanidipine and enalapril: more than mere blood pressure reduction
Enrico Agabiti Rosei
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
April 15, 2009
From macro- to microcirculation: benefits in hypertension and diabetes
Enrico Agabiti-Rosei
Hypertension (Dallas, Tex. : 1979)
|
June 22, 2016
Target Blood Pressure for Treatment: Should Current Recommendations Be Changed?
Enrico Agabiti Rosei
Therapeutic Advances in Cardiovascular Disease
|
April 27, 2010
Dronedarone: an emerging therapy for atrial fibrillation
Enrico Agabiti Rosei, Massimo Salvetti
Journal of Hypertension
|
March 30, 2017
Microvascular structure as a prognostically relevant endpoint
Enrico Agabiti-Rosei, Damiano Rizzoni
Thyroid : Official Journal of the American Thyroid Association
|
August 17, 2006
Fine needle aspiration cytology of thyroid nodule
Carlo Cappelli, Enrico Agabiti Rosei
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
April 15, 2009
Profile of patients with type 2 diabetes in France and Italy
Faiez Zannad, Enrico Agabiti-Rosei
Page
of 24
Search research articles
Search
Showing results (1-10 of 233) with videos related to
Sort By:
Page
of 24
Journal of Hypertension
|
May 23, 2002
Clinical value of diastolic dysfunction in hypertension
Enrico Agabiti Rosei
High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension
|
January 29, 2013
Reduction of Cardiovascular Risk through Angiotensin II Type 1 Receptor Antagonism : Focus on Olmesartan Medoxomil
Enrico Agabiti Rosei
Drugs
|
April 24, 2003
[Structural and functional changes of the microcirculation in hypertension: influence of pharmacological therapy]
Enrico Agabiti-Rosei
Current Medical Research and Opinion
|
October 26, 2016
The fixed-dose combination of lercanidipine and enalapril: more than mere blood pressure reduction
Enrico Agabiti Rosei
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
April 15, 2009
From macro- to microcirculation: benefits in hypertension and diabetes
Enrico Agabiti-Rosei
Hypertension (Dallas, Tex. : 1979)
|
June 22, 2016
Target Blood Pressure for Treatment: Should Current Recommendations Be Changed?
Enrico Agabiti Rosei
Therapeutic Advances in Cardiovascular Disease
|
April 27, 2010
Dronedarone: an emerging therapy for atrial fibrillation
Enrico Agabiti Rosei, Massimo Salvetti
Journal of Hypertension
|
March 30, 2017
Microvascular structure as a prognostically relevant endpoint
Enrico Agabiti-Rosei, Damiano Rizzoni
Thyroid : Official Journal of the American Thyroid Association
|
August 17, 2006
Fine needle aspiration cytology of thyroid nodule
Carlo Cappelli, Enrico Agabiti Rosei
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|
April 15, 2009
Profile of patients with type 2 diabetes in France and Italy
Faiez Zannad, Enrico Agabiti-Rosei
Page
of 24